Medchemexpress/Etomoxir/HY-50202/5mg-免疫在线蚂蚁淘旗下平台

当前位置：首页 > 产品中心 > Small_molecule > Medchemexpress/Etomoxir/HY-50202/5mg

商品详细Medchemexpress/Etomoxir/HY-50202/5mg

Medchemexpress/Etomoxir/HY-50202/5mg

商品编号： HY-50202-10mM*1mLinDMSO

品牌： MedChemExp

市场价： ¥1840.00

美元价： 1104.00

产地：美国(厂家直采)

公司：

产品分类：小分子

公司分类： Small_molecule

联系Q Q： 3392242852

电话号码： 4000-520-616

电子邮箱： info@ebiomall.com

立即询价

商品介绍

Etomoxirisapotentinhibitorofcarnitinepalmitoyltransferase-I(CPT-1).

CustomerValidation

•Oncotarget.2016Oct11;7(41):67071-67086.
•BiochemBiophysResCommun.2017Feb5;483(2):860-866.

Description	Etomoxirisapotentinhibitorofcarnitinepalmitoyltransferase-I(CPT-1).
IC₅₀&Target	CPT-1^[1]
InVitro	EtomoxirbindsirreversIBLytothecatalyticsiteofCPT-1inhibitingitsactivity,butalsoupregulatesfattyacidoxidationenzymes.Etomoxirisdevelopedasaninhibitorofthemitochondrialcarnitinepalmitoyltransferase-1(CPT-1)locatedontheoutermitochondrialmembrane.Etomoxir,inthelivercanactasperoxisomalproliferator,increasingDNAsynthesisandlivergrowth.Thus,etomoxir,inadditionofbeingaCPT1inhibitorcouldbeconsideredasaPPARalphaagoNIST^[1].EtomoxirisamemberoftheoxiranecarboxylicacidcarnitinepalmitoyltransferaseIinhibitorsandhasbeensuggestedasatherapeuticagentforthetreatmentofheartfailure.AcuteEtomoxirtreatmentirreversiblyinhibitstheactivityofcarnitinepalmitoyltransferaseI.Asaresult,fattyacidimportintothemitochondriaandβ-oxidationisreduced,whereascytosolicfattyacidaccumulatesandglucoseoxidationiselevated.Prolongedincubation(24h)withEtomoxirproducesdiverseeffectsontheexpressionofseveralmetabolicenzyme^[2].
InVivo	Etomoxirisaninhibitoroffreefattyacid(FFA)oxidation-relatedkeyenzymeCPT1.P53interactsdirectlywithBax,whichisinhibitedbyEtomoxir,furtherconfirmingthedirectinteractionofP53andBax,andtheinvolvementofFAO-mediatedmitochondrialROSgenerationindb/dbmice^[3].RatsareinjecteddailywithEtomoxir,aspecificCPT-Iinhibitor,for8daysat20mg/kgofbodymass.Etomoxir-treatedratsdisplaya44%reducedcardiacCPT-Iactivity.ThetreatmentofLewisratsfor8dayswith20mg/kgEtomoxirdoesnotalterbloodglucose,whichisinlinewithcomparableetomoxir-feedingstudies.Similarly,Etomoxirfeedingdoesnotaffectgeneralgrowthcharacteristicssuchasgaininbodymass,nordoesitaffecthindlimbmusclemass.However,heartmassandlivermassarebothsignificantlyincreasedby11%inEtomoxir-treatedrats^[4].
References	[1].RuppH,etal.Theuseofpartialfattyacidoxidationinhibitorsformetabolictherapyofanginapectorisandheartfailure.Herz.2002Nov;27(7):621-36. [2].XuFY,etal.EtomoxirmediatesdifferentialmetabolicchannelingoffattyacidandglycerolprecursorsintocardiolipininH9c2cells.JLipidRes.2003Feb;44(2):415-23. [3].LiJ,etal.FFA-ROS-P53-mediatedmitochondrialapoptosiscontributestoreductionofosteoblastogenesisandbonemassintype2diabetesmellitus.SciRep.2015Jul31;5:12724. [4].LuikenJJ,etal.Etomoxir-inducedpartialcarnitinepalmitoyltransferase-I(CPT-I)inhibitioninvivodoesnotaltercardiaclong-chainfattyaciduptakeandoxidationrates.BiochemJ.2009Apr15;419(2):447-55.

PreparingStockSolutions

ConcentrationVolumeMass	1mg	5mg	10mg

1mM	3.0598mL	15.2989mL	30.5979mL
5mM	0.6120mL	3.0598mL	6.1196mL
10mM	0.3060mL	1.5299mL	3.0598mL

Pleaserefertothesolubilityinformationtoselecttheappropriatesolvent.

CellAssay
^[2]

EtomoxirisdissolvedinDMSOandstored,andthendilutedwithappropriatemediumbeforeuse^[2].

RatheartH9c2myoblasticcellsareincubatedinDMEMcontaining10%fetalbovineserumuntilnearconfluence.Insomeexperiments,cellsarepreincubatedfor2hwithDMEM(serum-free)intheabsenceorpresenceof1-80μMEtomoxirandthenincubatedfor2hwith0.1mM[1-¹⁴C]oleicacid(10μCi/dish,bindstoBSAina1:1molarratio).Inotherexperiments,cellsarepreincubatedfor2hplusorminus40μMEtomoxirandthenincubatedfor2hwith0.1μMor0.1mM[1,3-³H]glycerol(10μCi/dish),0.1mM[1-¹⁴C]oleicacid(2μCi/dish,bindstoBSAina1:1molarratio),0.1mM[1-¹⁴C]palmiticacid(2μCi/dish,bindstoBSAina1:1molarratio),28μM[³H]ethanolamine(2μCi/dish),28μM[methyl-³H]choline(2μCi/dish),0.4mM[³H]serine(20μCi/dish),or40μMmyo-[³H]inositol(10μCi/dish).Themediumisremovedandthecellswashedtwicewithice-coldsalineandthenharvestedfromthedishwith2mLmethanol-water(1:1,v/v)forlipidextraction.AnaliquotofthehomogenateistakenforthedeterminationoftotaluptakeofrADIoactivityintocells.Phospholipidsarethenisolatedandradioactivityinthesedetermined^[2].MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.

AnimalAdministration
^[3]^[4]

Etomoxirisdissolvedin0.9%(w/v)NaCl(Rat)^[4].

Mice^[3]
80maleC57BLKS/Jlar-Lepr^db/dbmiceand20wildtypelittermates(8week)areused.db/dbmicearerandomlydividedintofourgroups:db/dbgroup,Etomoxirgroup,MitoQgroup,andPFT-αgroup.IntheEtomoxirgroup,miceareintraperitoneallyinjectedwith1 mg/kgEtomoxirtwiceeveryweek.IntheMitoQgroup,50 μMMitoQisgiventothemiceinwater.Waterbottles,containingeitherMitoQ,arecoveredwithaluminumfoil,andallbottlesarerefilledevery3days.InthePFT-αgroup,miceareintraperitoneallyinjectedwith1 mg/kgPFT-αtwiceeveryweek.WTmiceareadministratedwithvehicleinstead.Theexperimentalperiodis8weeks.Attheend,peripheralbloodsamplesandbonemarrowcellsareharvestedfortheassays.
Rat^[4]
MaleLewisrats,weighing150-200g,areusedinthepresentstudy.Animalsarekeptona12h:12hlight/darkcycleandfedaPurinaChowdietandwateradlibitum.Theratsaredividedintotwogroups:(1)controland(2)Etomoxir.Etomoxir(20mg/kgofbodyweight)isdissolvedin0.9%(w/v)NaClandadministeredintraperitoneallyfor8days.Controlratsreceivesaline.Thelastinjectionisgiven24hbeforetheexperiment.Animalsareanaesthetizedwithanintraperitonealinjectionofanembutalandheparin(3:1)mixture.Subsequently,theheartisremovedforLCFAuptakestudiesandforanalysesoftransporterproteincontents.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.

References

[1].RuppH,etal.Theuseofpartialfattyacidoxidationinhibitorsformetabolictherapyofanginapectorisandheartfailure.Herz.2002Nov;27(7):621-36.
[2].XuFY,etal.EtomoxirmediatesdifferentialmetabolicchannelingoffattyacidandglycerolprecursorsintocardiolipininH9c2cells.JLipidRes.2003Feb;44(2):415-23.
[3].LiJ,etal.FFA-ROS-P53-mediatedmitochondrialapoptosiscontributestoreductionofosteoblastogenesisandbonemassintype2diabetesmellitus.SciRep.2015Jul31;5:12724.
[4].LuikenJJ,etal.Etomoxir-inducedpartialcarnitinepalmitoyltransferase-I(CPT-I)inhibitioninvivodoesnotaltercardiaclong-chainfattyaciduptakeandoxidationrates.BiochemJ.2009Apr15;419(2):447-55.

MolecularWeight	326.82
Formula	C₁₇H₂₃ClO₄
CASNo.	124083-20-1
Storage	4°C,protectfromlight,storedundernitrogen
Shipping	RoomtemperatureincontinentalUS;mayvaryelsewhere
Solvent&Solubility	10mMinDMSO *"<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation=""> Purity:99.40% SelectBatch: